Showing results (1-10 of 371) with videos related to
Sort By:
Pageof 38
Pharmacoeconomics|April 28, 2018
Does Non-Adherence Increase Treatment Costs in Schizophrenia?Mark Pennington, Paul McCroneEvidence-Based Mental Health|May 26, 2019
Health state utility values in schizophrenia: protocol for a systematic review and meta-analysisDavid Aceituno, Mark Pennington, Barbara Iruretagoyena, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 17, 2020
Health State Utility Values in Schizophrenia: A Systematic Review and Meta-AnalysisDavid Aceituno, Mark Pennington, Barbara Iruretagoyena, et al.The British Journal of Psychiatry. Supplement|November 21, 2007
Health economic measures in schizophrenia researchPaul McCroneJournal of Pain and Symptom Management|July 21, 2009
Capturing the costs of end-of-life care: comparisons of multiple sclerosis, Parkinson's disease, and dementiaPaul McCroneChild and Adolescent Mental Health|December 10, 2024
Debate: Where to next for universal school-based mental health interventions? Universal versus targeted school-based mental health interventions: a health economic perspectivePaul McCroneOpen Heart|April 5, 2022
Cost-effectiveness in diagnosis of stable angina patients: a decision-analytical modelling approachMuhummad Sohaib Nazir, Yael Rodriguez-Guadarrama, Tiago Rua, et al.Applied Health Economics and Health Policy|March 16, 2013
The cost effectiveness of long-acting/extended-release antipsychotics for the treatment of schizophrenia: a systematic review of economic evaluationsEvanthia Achilla, Paul McCroneThe British Journal of Psychiatry : the Journal of Mental Science|November 3, 2016
Invited commentary … On poverty, politics and psychologyGlenys Parry, Paul McCronePageof 38